The CRISPR/dCas9 system was employed to elucidate the significance of transcription factor binding on MYCN locus, and found that the inhibition of OCT4 binding was found to be critical for MYCN expression in MYCN-amplified NB. This evidence concerns the gene MYCN and neuroblastoma.